RHYRHYTHM BIOSCIENCES LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 18:40 | ColoSTAT Commercial Rollout Update | Company Update | — | 11001 | |
| 6 Aug 2026, 18:38 | Bioshares 2026 Presentation | Presentations | — | 03026 | |
| 30 July 2026, 18:33 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 21 July 2026, 18:30 | New Lung Cancer Genetype Risk Assessment Test | Company Update | — | 11001 | |
| 7 July 2026, 18:26 | Accreditation Matters Conference Presentation | Presentations | — | 03026 | |
| 2 July 2026, 18:24 | Rhythm launches tailored ColoSTAT marketing campaign | Company Update | — | 11001 | |
| 4 June 2026, 18:24 | Rhythm Bio Singapore Investor Presentation | Presentations | — | 03026 | |
| 26 May 2026, 18:49 | ColoSTAT Access Program Gains Momentum | Company Update | — | 11001 | |
| 13 May 2026, 20:08 | Investor Presentation | Presentations | — | 03026 | |
| 6 May 2026, 18:28 | ColoSTAT Demonstrates Early Clinical Adoption | Company Update | — | 11001, 14014 | |
| 5 May 2026, 21:04 | Investor Webinar | Presentations | — | 14014 | |
| 30 Apr 2026, 19:31 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 03:24 | RHYO Underwriting Update | Company Administration | — | 06009, 12008 | |
| 18 Apr 2026, 02:28 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 16 Apr 2026, 03:04 | Cleansing Notice | Securities Administration | — | 06018 | |
| 16 Apr 2026, 02:45 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 15 Apr 2026, 02:53 | Response to ASX Query Letter | ASX Query | MS | 17003 | |
| 15 Apr 2026, 01:32 | Completion Of RHYO Option Underwriting | Securities Administration | — | 06009 | |
| 8 Apr 2026, 02:39 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 8 Apr 2026, 02:35 | Notification of cessation of securities - RHY | Other | — | 06027 | |
| 3 Apr 2026, 04:43 | Proposed issue of securities - RHY | Securities Administration | — | 06013 | |
| 3 Apr 2026, 04:41 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 31 Mar 2026, 20:25 | RHYO Options Underwriting Agreement | Securities Administration | — | 06009 | |
| 30 Mar 2026, 19:40 | Prospectus | Securities Administration | — | 06010 | |
| 30 Mar 2026, 19:23 | Rapid Expansion of ColoSTAT Commercial Roll Out | Company Update | — | 11001 | |
| 28 Mar 2026, 03:31 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 26 Mar 2026, 19:31 | First geneType Clinical Test Sale in South East Asia | Company Update | — | 11001 | |
| 21 Mar 2026, 03:52 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 18 Mar 2026, 19:36 | Accelerating the Commercial Rollout of ColoSTAT | Company Update | — | 11001 | |
| 18 Mar 2026, 19:26 | Investor Webinar Presentation | Presentations | — | 03026 | |
| 13 Mar 2026, 23:47 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 12 Mar 2026, 20:16 | Investor Webinar | Presentations | — | 14014 | |
| 11 Mar 2026, 19:28 | First ColoSTAT Clinical Test Sale | Company Update | MS | 11001 | |
| 9 Mar 2026, 20:10 | NATA Accredits ColoSTAT Clinical Testing Service | Company Update | MS | 11001 | |
| 6 Mar 2026, 21:07 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 4 Mar 2026, 19:57 | RHY Executes SE Asian Genetype Distribution Agreement | Company Update | MS | 11001 | |
| 28 Feb 2026, 03:27 | Cleansing Notice | Securities Administration | — | 06018 | |
| 28 Feb 2026, 03:22 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 27 Feb 2026, 21:06 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 27 Feb 2026, 20:24 | $5.5 million Secured for RHYO Options | Company Administration | — | 06009, 12008 | |
| 26 Feb 2026, 20:11 | NHS England ColoSTAT Evaluation Commences | Company Update | — | 11001 | |
| 25 Feb 2026, 19:44 | Proposed issue of securities - RHY | Securities Administration | — | 06013 | |
| 25 Feb 2026, 19:43 | Exercise of RHYO Options underwritten for $4.5m to $6.0m | Company Administration | MS | 06009, 09014, 12008 | |
| 23 Feb 2026, 20:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 21 Feb 2026, 02:14 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 19 Feb 2026, 01:14 | Half-Year Financial Report and Appendix 4D | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 17 Feb 2026, 19:39 | Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology | Company Update | MS | 11001 | |
| 17 Feb 2026, 04:02 | Application for quotation of securities - RHY | Other | — | 06020 | |
| 16 Feb 2026, 20:23 | Investor Presentation | Presentations | — | 03026 | |
| 11 Feb 2026, 19:32 | ColoSTAT commercial deployment - First physician enrolled | Company Update | MS | 11001 |
1–50 of 111
1 / 3